Home » Topics » Disease categories and therapies » Immune

Immune
RSS

Promising clinical results for Mologen's dSLIM compounds in cancer patients

July 8, 2003

APT-070 now holds orphan drug status in transplantation on two continents

July 7, 2003

Benzothiazole-based inhibitor of Lck with good cellular activity

July 4, 2003

DARPA grant will fund development of CpG TLR9 agonists for use with anthrax vaccine

June 27, 2003

Novel IMP dehydrogenase inhibitors under study at Celltech R&D

June 27, 2003

Genentech and Idec to develop humanized anti-CD20 antibodies

June 26, 2003

Immunogenicity study of StaphVAX gets under way

June 26, 2003

Emisphere and U.S. Army sign CRADA for oral anthrax vaccine

June 25, 2003

Isatoribine derivatives with improved pharmacokinetics reported by Anadys

June 25, 2003

FluINsure delivers strong immunogenicity data in phase II trials

June 23, 2003

Popular Stories

Today's news in brief
BioWorld
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...
VST Bio’s VB-001 is neuroprotector after stroke
BioWorld Science
At the recent International Stroke Conference, researchers from VST Bio Corp. and Yale University presented preclinical data regarding VB-001, a monoclonal...